Neurology 1009 - Neurology Alert - Sep 01, 2006

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Fred Plum, MD
University Professor;
Department of Neurology;
Cornell University Medical College

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Authors
Gregg L. Caporaso, MD, PhD
Assistant Professor
Neurology and Neuroscience
Weill Cornell Medical College

Sabiha Merchant, MD
Instructor
Pediatrics and Neurology
Weill Medical College
Cornell University

Joseph E. Safdieh, MD
Assistant Professor of Neurology
Weill Medical College
Cornell University

Melissa Nirenberg, MD
Assistant Professor of Neurology
Weill Cornell College of Medicine;
Associate Director
Weill Cornell Parkinson's
Disease & Movement Disorders Institute

Assistant Editors
Dara G. Jamieson, MD
Associate Professor
Clinical Neurology Director
Weill Medical College;
Neurovascular Ultrasound
Headache Center

Michael Rubin, MD
Professor of Clinical Neurology
NewYork Presbyterian Hospital
Cornell Campus

Subjects:

  • Telomeres, Dementia, and Mortality
  • Convulsive Status Epilepticus—Clinical Lessons from Epidemiologic Findings
  • Can Headaches Put the Heart at Risk? Yes, for Patients with Migraine with Aura
  • Does Hemodialysis Cause Dementia?
  • Teenage Polyneuropathy
  • Restless Legs Syndrome: A Disorder of Dopamine Neurotransmission

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Fred Plum, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Authors Gregg L. Caporaso, MD, PhD, Sabiha Merchant, MD, Joseph E. Safdieh, MD, and Melissa Nirenberg, MD report no financial relationship relevant to this field of study. Assistant editor Dara G. Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker's bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Assistant editor Michael Rubin, MD is on the speaker's bureau for Athena Diagnostics, and does research for Pfizer and Merck.

Copyright 2006 AHC Media. All rights reserved.